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Brain serotonin (5-HT) neurotransmission plays an important role in male sexual behavior
and it is well established that activating 5-HT1A receptors in rats facilitate ejaculatory
behavior. However, the relative contribution of 5-HT1A somatodendritic autoreceptors
and heteroreceptors in this pro-sexual behavior is unclear. Moreover, it is unclear
whether the contribution of somatodendritic 5-HT1A autoreceptors and postsynaptic
5-HT1A heteroreceptors alter when extracellular 5-HT levels are chronically increased.
Serotonin transporter knockout (SERT−/−) rats exhibit enhanced extracellular 5-HT
levels and desensitized 5-HT1A receptors. These rats model neurochemical changes
underlying chronic SSRI-induced sexual dysfunction. We want to determine the role
of presynaptic versus postsynaptic 5-HT1A receptors in the pro-sexual effects of 5-
HT1A receptor agonists in SERT+/+ and in SERT−/− rats. Therefore, acute effects
of the biased 5-HT1A receptor agonists F-13714, a preferential 5-HT1A autoreceptor
agonist, or F-15599, a preferential 5-HT1A heteroreceptor agonist, and S15535 a
mixed 5-HT1A autoreceptor agonist/heteroreceptor antagonist, on male sexual behavior
were assessed. A clear and stable genotype effect was found after training where
SERT+/+ performed sexual behavior at a higher level than SERT−/− rats. Both F-
15599 and F-13714 induced pro-sexual activity in SERT+/+ and SERT−/− animals.
Compared to SERT+/+, the F13714-dose-response curve in SERT−/− rats was shifted
to the right. SERT+/+ and SERT−/− rats responded similar to F15599. Within both
SERT+/+ and SERT−/− rats the potency of F-13714 was much stronger compared
to F-15599. S15535 had no effect on sexual behavior in either genotype. In SERT+/+
and SERT−/− rats that were selected on comparable low sexual activity (SERT+/+ 3
or less ejaculations and SERT−/− 5 or less ejaculations in 10 weeks) S15535 also did
not influence sexual behavior. The two biased compounds with differential effects on
5-HT1A auto- and hetero-receptors, exerted pro-sexual activity in both SERT+/+ and
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SERT−/− rats. Applying these specific pharmacological tools has not solved whether
pre- or post-synaptic 5-HT1A receptors are involved in pro-sexual activity. Moreover, the
inactivity of S15535 in male sexual behavior in either genotype was unexpected. The
question is whether the in vivo pharmacological profile of the different 5-HT1A receptor
ligands used, is sufficient to differentiate pre- and/or post-synaptic 5-HT1A receptor
contributions in male rat sexual behavior.
Keywords: serotonin, male sexual behavior, rat, 5-HT1A receptor, serotonin transporter, 5-HT1A autoreceptors,
5-HT1A heteroreceptors
INTRODUCTION
The serotonergic system plays an important modulatory role in
sexual behavior (Uphouse and Guptarak, 2010; Olivier et al.,
2019). This is, for example, illustrated by the effects of chronic
SSRI treatment in depressed patients that results in enhanced
5-HT levels often causing sexual dysfunctions like in men
delayed ejaculation and libido problems (Segraves and Balon,
2014). Early studies in male rats identified 5-HT1A receptor
(R) agonists like 8-OH-DPAT, the azapirones (e.g., buspirone,
ipsapirone, and gepirone) and others (e.g., flesinoxan) as pro-
sexual drugs (Ahlenius et al., 1981; Ahlenius and Larsson,
1985; reviewed in: Snoeren et al., 2014). The prototypal 5-
HT1A receptor agonists (±) and (+) – 8-OH-DPAT, potently
stimulate male rat sexual behavior; in a certain time frame
(e.g., 30 min), the number of ejaculations increases associated
with shortened ejaculation latencies and fewer intromissions to
reach ejaculation (Hillegaart and Ahlenius, 1998; Uphouse and
Guptarak, 2010; Chan et al., 2011). Although (±) 8-OH-DPAT
has also 5-HT7 R agonistic effects (Thomas et al., 1999), this
mechanism cannot explain the pro-sexual effects because other
5-HT1A receptor agonists without 5-HT7 R agonistic activity,
also display pro-sexual effects (Snoeren et al., 2014). 5-HT1A
receptors are present as presynaptic inhibitory autoreceptors on
soma and dendrites of raphé serotonergic neurons projecting
to many forebrain areas (Fernandez-Guasti et al., 1992; Le Poul
et al., 1995; Marek, 2010; Altieri et al., 2013). Moreover, 5-
HT1A receptors are also present as post-synaptic heteroreceptors
in various brain areas, mainly in the forebrain (Frink et al.,
1996; Garcia-Garcia et al., 2017). Systemic acute administration
of non-selective 5-HT1A receptor agonists like (±)-8-OH-DPAT
and flesinoxan (activation of pre- and post-synaptic receptors)
leads to decreased serotonergic release, but at the same time
to activation of post-synaptic 5-HT1A heteroreceptors (Müller
et al., 2007; Lladó-Pelfort et al., 2012). These non-selective 5-
HT1A receptor agonists often display biphasic dose-response
curves, and it is suggested that low doses of 8-OH-DPAT
preferentially activate autoreceptors, whereas higher doses of 8-
OH-DPAT preferentially activate post-synaptic heteroreceptors
(De Vry et al., 2004; Depoortère et al., 2019). However, in
male sexual behavior 8-OH-DPAT exerts a linear dose-dependent
increase in sexual activities, without any evidence for differential
effects on 5-HT1A auto- or heteroreceptors (Mos et al., 1991).
The pro-sexual effects of these non-selective 5-HT1A receptor
agonists are therefore not yet explained in terms of pre- or
post-synaptic mechanisms. To further explore the role of pre- and
post-synaptic 5-HT1A receptors in male sexual behavior, more
recently developed selective and high-affinity 5-HT1A receptor
agonists are useful. These so-called “biased” or “functionally
selective” agonists (Newman-Tancredi, 2011; Garcia-Garcia et al.,
2014) display selectivity for either pre- or post-synaptic 5-
HT1A receptors. F15599 is a high-affinity, selective 5-HT1A
receptor agonist (Ki = 3.4 nM) for post-synaptic 5-HT1A
heteroreceptors, whereas F13714 (Ki = 0.1nM) is a preferential
5-HT1A autoreceptor agonist (Koek et al., 2001; de Boer and
Newman-Tancredi, 2016; Hazari et al., 2017). In contrast to 8-
OH-DPAT, both F15599 (Newman-Tancredi et al., 2009) and
F15714 (Assié et al., 2006) are devoid of 5-HT7 receptor activity.
We studied both compounds in a dose-response study in male
rat sexual behavior. Another high-affinity (Ki = 1.8 nM) 5-HT1A
receptor ligand, S-15535 acts in vivo as a preferential agonist at
presynaptic autoreceptors and as antagonist at post-synaptic 5-
HT1A heteroreceptors (Millan et al., 1993; Carli et al., 1999).This
compound is an interesting tool to study in male sexual behavior
as it may shed further light on the complex role of 5-HT1A
receptors in male rat sexual behavior.
As mentioned before, chronic SSRI treatment results in
enhanced 5-HT levels often causing sexual dysfunctions
(Segraves and Balon, 2014). The exact mechanisms for these
dysfunctions remain unclear, but are high likely due to
alterations in the 5-HT1A receptor. Male rats lacking the
serotonin transporter (SERT−/−) display a robust genotype that
has a lower basal ejaculatory performance than wildtype rats
(SERT+/+) or heterozygous serotonin transporter knockout
(SERT+/−) rats (Chan et al., 2011; Esquivel-Franco et al., 2018).
More specific, due to the lack of the serotonin transporter
SERT−/− rats have a nine-fold increase in extracellular 5-HT
levels (Homberg et al., 2007), decreased number of ejaculations
and an increased ejaculation latency (Chan et al., 2011) compared
to SERT+/+ rats. This genetic animal model has therefore been
proposed and used as an animal model of spontaneous or SSRI-
induced delayed ejaculation in humans. Chronic SSRI use in men
may result in several side-effects including increased ejaculation
threshold, resulting in a delayed ejaculation latency or sometimes
even absent ejaculation, associated with a reduction in sexual
desire (Waldinger et al., 1998; Hirschfeld, 2003; Balon, 2006;
Rubio-Casillas et al., 2015). This is believed to be caused by the
combination of enhanced 5-HT levels and diminished 5-HT1A
receptor functioning (both pre- and post-synaptic) similar to
chronic SSRI-treatment in normal animals (Chan et al., 2011),
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or short acting SSRIs like dapoxetine in fast ejaculating rats
(Clément et al., 2012). Although conflicting findings on the
effects of acute and chronic SSRI treatment have been reported,
Clément et al. (2012) mention this is explained by distinct
pharmacokinetics rather than pharmacodynamic properties as
dapoxetine has rapid peak plasma concentrations which delays
ejaculation frequencies in men with premature ejaculation. In
rats the dapoxetine profile is less clear, although it is suggested
by the authors that in faster ejaculating rats dapoxetine seems to
delay the ejaculation latency (Clément et al., 2012). In particular
this 5-HT1A receptor desensitization phenomenon is relevant
here to further provide more clarity as to the potency of the
biased agonists to stimulate sexual behavior. SERT−/− rats have
higher extracellular serotonin levels than SERT+/+ animals
which is comparable to levels after chronic SSRI administration
(Homberg et al., 2007). Pharmacological experiments in these
rats indicated that rats lacking the SERT have altered 5-HT1A
receptor reactivity; the altered 5-HT1A receptor functioning is
probably not a global phenomenon, but might be limited to some
specific subpopulations of 5-HT1A receptors (not necessarily pre-
or post-synaptic), as indicated by changed autonomic responses
like core body temperature in SERT+/+ and SERT−/− animals.
The 5-HT1A receptor population involved with hypothermia was
not sensitive, while the 5-HT1A receptor population involved
with hyperthermia was still sensitive (Homberg et al., 2008;
Olivier et al., 2008). Experiments performed in male sexual
behavior (Chan et al., 2011) also indicated that likely at least two
populations of 5-HT1A receptors are involved in its expression.
However, it is worthwhile to mention that 5-HT1A receptors can
co-localize with 5-HT7 receptors in the cell-membrane (Renner
et al., 2012). It has been postulated that heterodimerization of
these receptors may influence the desensitization of 5-HT1A
autoreceptors caused by SSRIs (Naumenko et al., 2014). In
addition, 5-HT1A receptors are G-protein coupled receptors
activating different intracellular signaling pathways, which are
brain region specific. Activation of different G-protein cascades
may therefore play a role in the activation of 5-HT1A receptors
in specific cellular environments, while having no effect on other
subpopulations of the same receptor (Newman-Tancredi, 2011).
For performing sexual behavior, activation of one population
of 5-HT1A receptors is needed and we postulated that this
pool is desensitized in SERT−/− rats. The pro-sexual effects
of 8-OH-DPAT are probably mediated via 5-HT1A receptors,
which are not changed or somewhat less sensitive in SERT−/−
rats. This difference makes the SERT−/− rat a further attractive
model to test the different 5-HT1A receptor-modulating drugs,
F15599, F13714 and S-15355, as it may provide information on
the adaptation of pre- and post-synaptic 5-HT1A receptors due
to chronic high 5-HT levels, which may aid in the treatment of
sexual dysfunction caused by SSRI treatment.
Finally, we selected male rats that, after extensive training
(Pattij et al., 2005), display a low level of sexual behavior,
i.e., low number of ejaculations. Because 5-HT1A receptor
agonists facilitate ejaculation, a too high initial level of the
number of ejaculations would probably interact with the pro-
sexual effects of these drugs. The purpose of this study
was to use functionally selective agonists for either pre-
or post-synaptic 5-HT1A receptors to identify the role of
somatodendritic (auto) receptors and post (hetero) receptors
in sexual behavior. A second goal was to use SERT−/−
rats because they model SSRI-induced delayed ejaculation in
humans, and hence may provide insight in the adaptation
of specific 5-HT1A hetero- or auto receptors due to chronic
increased extracellular 5-HT levels. Thus, we investigated
whether chronic exposure to high 5-HT levels affected the pro-
sexual effects of 5-HT1A agonists, and whether pre- or post-
synaptic receptors were differently affected in SERT−/− rats
compared to SERT+/+ rats. We used F13714, F15599, and S15535
in normal (SERT+/+) and SERT−/− rats, and hypothesized
that these drugs would have differential effects on sexual
behavior and that SERT−/− rats would display desensitized
response to these drugs.
MATERIALS AND METHODS
Animals
Wistar rats were bred in our animal facility (University of
Groningen, GELIFES) using serotonin transporter (SERT)
heterozygous males and females, resulting in male and female
SERT wild type (SERT+/+), heterozygous (SERT±) and
homozygous or knock out (SERT−/−) rats. On postnatal day
21 pups were weaned and ears were punched for individual
recognition and genotyped as reported previously (El Aidy et al.,
2017). We used two groups of animals, the first one (normal
ejaculating rats) consisting of sixty-three male SERT (SERT+/+,
n = 32), and (SERT−/−, n = 31) rats and the second one (slow
ejaculating rats) of 32 male (16 SERT+/+ and 16 SERT−/−)
rats, all of them of at least 12 weeks old when used for sexual
behavior experiments.
Female SERT± and SERT+/+ were used as sexual stimulus
females (n = 120) as SERT+/+ and SERT± rats do not differ
in basal sexual activity (Snoeren et al., 2010). Rats were housed
under reversed dark-light conditions (12 h light:12 h dark,
lights off from 8:00 AM to 8 PM). After 6-weekly training tests
(30 min/test), male rats were considered sexually trained and
classified based on ejaculation frequencies per test. Male rats
display, after extensive training, a rather stable sexual phenotype
(Pattij et al., 2005; Olivier et al., 2006; Chan et al., 2008). In these
experiments, for the normal ejaculating 24 rats were selected
(from 14 different dams, a maximum of 3 SERT+/+ and/or
3 SERT−/− rats were used from the same litter) that showed
a normal ejaculatory phenotype (between 1 and 2 ejaculations
per test after training, for the last three sessions) and for
the slow ejaculating rats 20 (from 8 dams, a maximum of 5
SERT+/+ and/or 2 SERT−/− rats were used from the same litter)
that showed a rather low sexual phenotype (between 0 and 1
ejaculation per test after training, for the last three sessions)
were selected. We summed all ejaculations per rat for all training
weeks in Supplementary Figure 1 (group 1) and 2 (group 2).
The most left tail-side of the distribution was selected. Animals
were socially housed (2–5 per cage, maximum 4 for males).
Cages were enriched with wooden gnawing blocks and nesting
material (Envirodri).
Thus, to select normal ejaculating rats 32 SERT+/+ and 31
SERT−/− rats were sexually trained for 6 weeks and a total
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of 12 SERT+/+ and 12 SERT−/− rats were selected with a
normal average number of ejaculations. For selection of the
slow ejaculating rats 16 SERT+/+ and 16 SERT−/− rats were
sexually trained for 6 weeks and a total of 10 SERT+/+ and
10 SERT−/− rats were selected with a normal and low average
number of ejaculations (because this enhances the sensitivity of
the anticipated improvement in sexual behavior by the 5-HT1A
compounds and to match the control group as much as possible
to the knock-out animals). Experiments in the normal ejaculating
rats lasted 13 weeks in total (after training), and 4 weeks in total
(after training) for sow ejaculating rats. Animals were used only
once a week to guarantee sufficient drug washout time. Rats had
ad libitum access to food and water. This study was carried out in
accordance with the principles of the EU Directive 2010/63/EU.
All efforts were made to minimize the number of animals and
their suffering.
Female Rats
Female stimulus rats were tubal ligated in order to prevent
pregnancies. To perform tubal ligation surgery, females were
anesthetized (Isoflurane) and given pain relief (Fynadine,
0.1 mg/100 g) before surgery, and 24 and 48 h after surgery.
Females were at least 12 weeks old when surgery was performed,
and 2 weeks of recovery were given before they were made
intentionally receptive with estradiol (50 µg in 0.1 ml oil, S.C.,
36–48 h before the test) before the sexual behavior training tests
and experiments. Females were used not more than once in
2 weeks and not more than two times per experimental day.
Drug Treatment and Behavioral
Experiments
For the first experiment in normal ejaculating rats, animals
received all dosages of F13714 and F15599 in a crossover-
randomized design in order to prevent order effects; after this
experiment, S15535 was administered in a randomized design.
For the second experiment in slow ejaculating rats, animals
were only administered S15535 in a randomized design similar
to the first set of animals. As described previously in Olivier
et al. (2017), when pharmacological tests are performed, male
rats are given a 30-min habituation time in the test boxes right
after drug administration via IP injection, before the female
rat is introduced. All behavior during the 30-min test is video-
recorded after introduction of the female and were also live-
scored; the following parameters of the ejaculation series were
deduced (Chan et al., 2011): number of ejaculations/test (E),
number of mounts (M), number of intromissions (I), latency
(s) to first mount (ML), latency (s) to first intromission (IL)
and latency (s) to the first ejaculation (EL). After ejaculation,
the post ejaculatory latency (PEL(s)) was calculated, using
the time from the first ejaculation and the time of the first
mount/intromission (whatever occurred first) of the second
ejaculation series. Intromission Ratio (IR) was calculated as:
IR = (#I/(#I + #M)) × 100%. EL was calculated using the time
of the EL from the first ejaculation series minus the intromission
latency of the first ejaculation series (EL = EL – IL). These
parameters were used to run the statistical analysis.
Because it is important to have comparable
pharmacodynamics and kinetics in pharmacological studies, a
test of fixed duration has been chosen: 30 min (1800 s). In the
cases where drug-treatment had no “effect” on ejaculation and
sexual behavior, or few or no animal achieved a first ejaculation it
was not possible to perform statistical analyses and for those cases
we assigned values of 1800 s (i.e., the maximum test duration) for
some latencies (ejaculation, mount and intromission latency),
although this is undoubtedly a matter of discussion as we have
discussed before (Chan et al., 2011; Olivier et al., 2017). All tables
and figures show the results for the first Ejaculation Series only.
Drugs
F15599 and F13714 (Pierre Fabre Pharmaceuticals, France; Lot
# SBR1401003 and # JLM3001201, resp.) and S-15535 (Servier
Pharmaceuticals, France; Lot B01JLP061A) were dissolved in
NaCl 0.9% (saline) and each solution was freshly prepared on
each testing day. All drugs were administered via intraperitoneal
(IP) injection 30 min before the test.
Training (Table 1)
For the normal ejaculating group, rats were sexually trained for 6
times (30 min, once a week). For the slow ejaculating group, rats
were sexually trained 10 times (30 min, once a week). The latter
animals received extra training due to the extreme low sexual
performance to assess and stabilize their basal sexual activity.
Rats habituated for 10 min to the testing box right before the
training session. After the habituation period a receptive female
was introduced in the box and sexual behavior was assessed
for 30 min. Non-receptive females were switched for a different
receptive female. The training and testing occurred in wooden
rectangular (57 cm × 82 cm × 39 cm; glass wall) testing boxes
filled with regular bedding material. To stimulate sexual behavior,
bedding material was not changed during the training and testing
to preserve pheromones of previous rounds and to create a more
competitive sexual environment.
Only males showing stable normal (1–2 ejaculations, for
experiments 1 and 2 and low (0–1 ejaculations for experiment 3)
ejaculation levels in the last three tests were used in the
TABLE 1 | Overview of training of the various genotypes and pharmacological
experiments in selected male rats.








32 SERT+/+ Exp. 1: 12 SERT+/+ F15599 (0.01,0.04,
0.16,




Exp. 2: 12 SERT+/+ S15535 (0, 0.25, 1,




16 SERT+/+ Exp. 3: 10 SERT+/+ S15535 (0, 0.25, 1,
and 4-mg/kg, IP)
16 SERT−/− 10 SERT−/−
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pharmacological experiments. For Experiments 1 and 2 (normal
ejaculating rats) 24 rats were selected (N = 12 per genotype).
In Experiment 3 (slow ejaculating rats) 20 animals were
selected (10 per genotype). All training sessions and experiments
were performed under red light conditions between 10:00
AM and 17:00 PM.
Pharmacological Experiments (Table 1)
Experiment 1 (Normal Ejaculating Rats): F15599 and
F13714 Dose Response
Twenty-four normal ejaculating male rats were selected (N = 12
per SERT genotype) and were tested in a crossover design. Rats
received vehicle (saline), 0.01, 0.04, 0.16, and 0.64-mg/kg F15599
and 0.0025, 0.01, 0.04, and 0.16-mg/kg F13714 via intraperitoneal
(IP) administration. Experiments were performed once per week
on the same testing day, over 9 weeks and animals and treatment
were randomized over the 9 weeks. Although the experiments
with these two drugs were performed together, we performed the
statistical analysis separately for each compound.
Experiment 2 (Normal Ejaculating Rats): S15535 Dose
Response
The same 24 animals from experiment one received vehicle
(saline), 0.25, 1 and 4-mg/kg S15535, IP in a randomized
design. Testing was performed over 4 weeks and always on the
same day per week.
Experiment 3 (Slow Ejaculating Rats): S15535 Dose
Response
10 SERT+/+ and 10 SERT−/− rats were selected for low
numbers of ejaculation. Rats received vehicle (saline), 0.25, 1,
and 4-mg/kg S15535, via IP administration in a randomized
design. Testing was performed over 4 weeks and always on the
same day per week.
Statistical Analyses
Differences in baseline ejaculation numbers during the training
between genotypes were analyzed using two-way ANOVA for
repeated measures, with genotype as between- and time (weeks)
as within-subjects factors. Where appropriate, an independent
t-test was performed. For the F19955, F13714, and S15535 dose-
response experiments, a two-way ANOVA for repeated measures
was performed with dose as within-subject factor (5 levels) and
genotype as between-subject factor (2 levels). Where appropriate
one way-ANOVA with LSD post hoc was performed. All statistical
analyses were performed using the Statistical Package for Social
Sciences for Windows version 25 (LEAD technologies, Chicago,
United States). Level of significance was set at p < 0.05.
RESULTS
Sexual Stability
The sexual performance of the selected experimental animal
groups that exhibited a normal (1–2 ejaculations) and a low basal
ejaculation frequency (0–1 ejaculation) during the six training
days was registered and from the 63 male rats sexually trained
from the first group and 32 from the second group, only 24 and 20
animals (respectively) that showed stable normal and low sexual
performance and ejaculations respectively, were selected to run
the pharmacological studies (see Supplementary Figures 1, 2).
For the first group (selection for normal ejaculation rats), there
was a significant week (time) effect F(7.154) = 13.86, p < 0.001,
a significant week × genotype effect F(7.154) = 3.40, p < 0.01
and a significant genotype effect (F(1,22) = 23.81, p < 0.001). In
SERT+/+ rats from week 3 onward they performed significant
more ejaculations (all p-values are < 0.05) compared to the first
2 weeks (Figure 1 and Table 2). In SERT−/− rats only week 16–20
significantly differed (all p-values are < 0.05) from all other weeks
(Figure 1 and Table 2). SERT−/− rats ejaculated significantly
less compared to SERT+/+ rats in week 3 (p < 0.05), week 4
(p < 0.05), week 5 (p < 0.05), week 6 (p < 0.05), weeks 7–14
(0.05), and weeks 16–20 (p < 0.01).
For the second group of animals trained (for selection of slow
ejaculating rats), there was a significant difference in weeks of
training (F(10,180) = 3.453, p < 0.001). In week 11–14, SERT+/+
and SERT−/− rats had significant more ejaculations compared to
all other weeks (all p-values < 0.01). No significant differences
in time × genotype, and genotype effects were found during the
training weeks (Figure 2 and Table 3).
We included in Figure 1 the saline data gathered in the
pharmacological experiments performed on animals in group
one (selection for normal ejaculating rats). The saline data
obtained for all animals in weeks 7–15 (Exp. 1) were comparable
to the last training data, but the saline data from the last (S15535)
experiment (Exp. 2) (during week 16–20) showed significantly
higher values. This “enhanced” baseline level of sexual behavior
made us decide (because of possible ceiling effects) to repeat
the S15535 experiment in rats with very low levels of sexual
ejaculation activity (group two, Exp. 3: data shown in Table 3). In
FIGURE 1 | Mean ejaculation frequencies (±SEM) over 6 weeks of training of
male Wistar rats of group one (selection for normal ejaculating rats). Added
are also the mean ± SEM of the saline data from experiment one (F13714 and
F15599) and two (S15535) of group one. a: significantly different (p < 0.05)
from week 1; b: significantly different (p < 0.05) from week 2;c: significantly
different (p < 0.05) from week 3; d: significantly different (p < 0.05) from week
4; e: significantly different (p < 0.05) from week 5; f: significantly different
(p < 0.05) from week 6; g: significantly different (p < 0.05) from week 7 to 15;
*significantly different (p < 0.05) from SERT+/+. Detailed statistical analyses
are provided in Table 2.
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FIGURE 2 | Mean ejaculation frequencies (±SEM) over 10 weeks of training of
male Wistar rats of group two (selection for slow ejaculating rats). Added is
also the mean ± SEM of the saline data from S15535 experiment (week
11–14). a: significantly different (p < 0.05) from week 1; b: significantly
different (p < 0.05) from week 2; c: significantly different (p < 0.05) from week
3; d: significantly different (p < 0.05) from week 4; e: significantly different
(p < 0.05) from week 5; f: significantly different (p < 0.05) from week 6; g:
significantly different (p < 0.05) from week 7; h: significantly different
(p < 0.05) from week 8; i: significantly different (p < 0.05) from week 9; j:
significantly different (p < 0.05) from week 10; *significantly different (p < 0.05)
from SERT+/+. Detailed statistical analyses are provided in Table 3.
Figure 2 we also included the saline data gathered in the S15535
dose-response experiment (Exp. 3) of the second group (week
11–14). Again, an enhanced baseline level of sexual behavior
was found in the saline treated animals during the S-155355
treatment weeks.
Dose-Response of F15599 (Figure 3 and
Supplementary Table 1)
In the dose-response experiment significant dose (F(4,88) = 8.75;
p < 0.001) and genotype (F(1,22) = 22.278; p < 0.001) effects,
but no interactions, were found for the number of ejaculations.
Comparable significances were found for ejaculation latencies
and intromission ratios (see Supplementary Table 1 for statistics
of all behavioral parameters). Further analysis revealed that the
lowest and intermediate doses of F15599 (0, 0.01, 0.04, and
0.16 mg/kg) had no significant effects on sexual behavior in either
genotype (Figure 3 and Supplementary Table 1). Compared to
saline (p < 0.001), 0.01 (p < 0.01), and 0.04 (p < 0.001) mg/kg
doses of F-15599, the highest dose (0.64 mg/kg) significantly
increased the ejaculation frequency. Moreover, ejaculation
latencies were significant shorter in 0.64 mg/kg F15599 compared
to saline (p < 0.01), 0.01 mg/kg (p < 0.05), and 0.04 mg/kg
(p < 0.01) F15599 (Figure 3 and Supplementary Table 1) in
both SERT+/+ and SERT−/− animals; the 0.64 mg/kg F15599
dose also significantly increased the efficiency of the animals to
ejaculate (IR; p < 0.05; Figure 3 and Supplementary Table 1)
compared to saline (p < 0.01), 0.01 mg/kg (p < 0.05), and
0.04 mg/kg (p < 0.05) of F15599.
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A significant decrease in the number of ejaculations of
SERT−/− rats was found compared to SERT+/+ rats in the
saline treatment (p < 0.05), and in the 0.01 mg/kg (p < 0.05),
0.04 mg/kg (p < 0.05), 0.16 mg/kg (p < 0.05), and 0.64 mg/kg
(p < 0.05) F15599 treatment. Similarly, an increase in ejaculation
latency was found for SERT−/− rats compared to SERT+/+ rats
in saline treatment (p < 0.001), and in 0.01 mg/kg (p < 0.01),
0.04 mg/kg (p < 0.001), 0.16 mg/kg (p < 0.05), and 0.64 mg/kg
(p < 0.001) F15599 treatment. For the intromission ratio, a
significant decrease was found for SERT−/− rats compared
to SERT+/+ rats in saline treatment (p < 0.05), and in the
0.01 mg/kg (p < 0.01), 0.04 mg/kg (p < 0.05), and 0.16 mg/kg
(p < 0.05) F15599 treatment.
Dose-Response of F13714 (Figure 4 and
Supplementary Table 2)
Overall, F13714 induced pro-sexual effects in both genotypes,
although the dose-effect curves for both genotypes differed
considerably (Figure 4 and Supplementary Table 2).
Considering ejaculations, significant dose (F(4,88) = 3.287,
p < 0.05), genotype (F(1,22) = 20.649, p < 0.001), and
genotype × dose interactions (F(4,88) = 4.810, p < 0.01)
were found. Comparable significances were found for ejaculation
latencies (see Supplementary Table 2 for statistics of all
behavioral parameters). In SERT+/+ rats, F13714 stimulated
sexual behavior significantly, illustrated (compared to saline)
in the increase in ejaculation frequencies at 0.0025 mg/kg
(p < 0.01), 0.01 mg/kg (tendency; p = 0.06), and 0.04 mg/kg
(p < 0.05) mg/kg F13714. In the SERT−/− rats, pro-sexual
effects were observed only at the highest dose (0.16 mg/kg)
compared to saline (p < 0.05) and 0.025 mg/kg (p < 0.05) of
F13714. Although the ejaculation latency was decreased at this
high dose for both genotypes, the difference was not statistically
significant. The number of mounts was equally decreased in
SERT+/+ and SERT−/− rats at 0.16 mg/kg F13714 compared to
saline (p < 0.01), 0.025 mg/kg (p < 0.01), 0.01 mg/kg (p < 0.001)
and 0.04 mg/kg (p < 0.05) F13714. In SERT+/+, but not in
SERT−/−, rats, the intromission latency was enhanced at the
highest dose (F(4,55) = 4.203, p < 0.01). The intromission latency
at the highest dose (0.16 mg/kg) of F13714 was significant
longer compared to saline (p < 0.01), 0.0025 mg/kg (p < 0.001),
0.01 mg/kg (p < 0.01), and 0.04 mg/kg (p < 0.05) F13714.
Lastly, the number of intromissions was significantly decreased
in SERT+/+ rats only (F(4,55) = 8.194; p < 0.001). Intromissions
were significant reduced in animals treated with 0.16 mg/kg
F13714 compared to saline (p < 0.001), 0.0025 mg/kg (p < 0.01)
and 0.01 mg/kg (p < 0.01) F13714 treated SERT+/+ rats.
In addition, 0.04 mg/kg F13714 treated SERT+/+ rats had a
significant reduced number of intromissions compared to those
treated with saline (p < 0.001), 0.0025 mg/kg (p < 0.01), and
0.01 mg/kg (p < 0.05) F13714.
SERT−/− rats had significant lower ejaculation frequencies
compared to SERT+/+ rats after treatment with saline (p< 0.05),
and after treatment with 0.0025 mg/kg (p < 0.01), 0.01 mg/kg
(p < 0.01), and 0.04 mg/kg (p < 0.01) F13714. For mounts,
only at a dose of 0.04 mg/kg F13714 SERT−/− rats showed a
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FIGURE 3 | Sexual behavior of male rats treated with 0, 0.01, 0.04, 0.16, or 0.64 mg/kg, IP of F-15599. The number and latency of ejaculations per 30 min (A,D),
number and latency of Mounts (B,E), number and latency of Intromissions (C,F) and Intromission Ratio (G) of the first Ejaculation Series are displayed. Detailed
statistical analyses are provided in Supplementary Table 1. a: significant difference (p < 0.05) compared to saline group, b: significant difference (p < 0.05)
compared to 0.01mg/kg group, c: significant difference (p < 0.05) compared to 0.04/mg/kg group. +Significant difference between SERT+/+ and SERT−/−
(p < 0.05).
significant higher mount frequency (p < 0.01) compared with
SERT+/+ rats. At the same dose SERT−/− rats also showed a
higher intromission frequency compared to SERT+/+ rats. For
latency to the first ejaculation a significant increase was found
for SERT−/− rats compared to SERT+/+ rats for all doses (all
p-values < 0.01). The latency to the first mount was significantly
higher for SERT−/− rats compared to SERT+/+ after saline
treatment (p < 0.05) and the latency to the first intromission was
also significantly higher for SERT−/− rats compared to SERT+/+
at 0.0025 mg/kg F13714 (p < 0.05).
Dose-Response of S15535 (Figures 5, 6
and Supplementary Tables 3, 4)
S15535 (0.25, 1, and 4-mg/kg) had no significant effects on sexual
behavior in SERT+/+ and SERT−/− (Figures 5, 6) compared
to saline in either group of animals (Exp. 2 and 3). In the
normal ejaculating rats (Exp. 2), a significant genotype effect for
ejaculation frequencies was found (F(1,22) = 21.167, p < 0.001;
Figure 5A). SERT+/+ rats had significant higher ejaculation
frequencies after treatment with saline (p < 0.001), 0.25 mg/kg
(p < 0.001), 1 mg/kg (p < 0.05), and 4 mg/kg (p < 0.001)
S15535 in comparison with SERT−/− rats. Similar effects were
found for the ejaculation latency (F(1,22) = 25.627, p < 0.001;
Figure 5D and Supplementary Table 3) where there was an
increase for SERT−/− versus SERT+/+ animals after saline
treatment (p < 0.001), and after treatment with 0.25 mg/kg
(p < 0.05), 1 mg/kg (p < 0.05), and 4 mg/kg (p < 0.001) S15535,
and to some extent in the intromission ration, although this was
only significant in the saline treated (p < 0.05) and 4 mg/kg
(p < 0.05) S155355 treated group.
In the slow ejaculating rats (Exp. 3), no significant differences
were found in the majority of parameters measured, although
a significant dose effect was found for the number of mounts
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FIGURE 4 | Sexual behavior of male rats treated with 0, 0.0025, 0.01, 0.04, or 0.16 mg/kg F13714. The number and latency of ejaculations per 30 min (A,D),
number and latency of Mounts (B,E), number and latency of Intromissions (C,F), and Intromission Ratio (G) of the first Ejaculation Series are provided. Detailed
statistical analyses are displayed in Supplementary Table 2. a: significant difference (p < 0.05) compared to saline group, b: significant difference (p < 0.05)
compared to 0.0025mg/kg group, c: significant difference (p < 0.05) compared to 0.01/mg/kg group. +Significant difference between SERT+/+ and SERT−/−
(p < 0.05).
(F(3,54) = 3.077, p < 0.05). Analysis revealed a significant
reduction in the number of mounts between saline and
0.025 mg/kg (p < 0.05), between saline and 4 mg/kg S-155355
(p < 0.05) and between 0.025 and 1 mg/kg S-155355 (p < 0.05).
In addition, a genotype effect was found in the latency to the first
intromission (F(1,18) = 5.786, p < 0.05). Compared to SERT+/+,
SERT−/− displayed a shorter latency to the first intromission
(p < 0.05; see Figure 6 and Supplementary Table 4).
Comparison Between F15599 and
F13714 (Supplementary Figure 3)
A fit curve plot for SERT+/+ and SERT−/− rats on a log
scale (see Supplementary Figure 3) was made where data
were normalized against the saline treated group. The ED50
was calculated for SERT+/+ (F15599, ED50 = 0.21 mg/kg;
F13714, ED50 = 0.0065 mg/kg) and SERT−/− (F15599,
ED50 = 0.165 mg/kg; F13714, ED50 = 0.00178 mg/kg) and
illustrated that F13714 was more potent compared to F15599
in both SERT+/+ and SERT−/− rats. The curved fit plot also
showed that SERT−/− rats were sensitive to both compounds,
as they were able to increase the percentage of ejaculations
compared with the saline treated group.
DISCUSSION
In the present study, after extensive training of the two genotypes
studied (SERT+/+ and SERT−/−), animals showed two different
but stable sexual phenotypes, confirming earlier findings (Chan
et al., 2011) where male SERT+/+ rats performed sexual behavior
at a higher level than SERT−/− rats. Permanent changes in
serotonergic processes in the central nervous system by removing
the SERT protein from conception on (Chan et al., 2011; Olivier
et al., 2011), apparently leads to permanent changes in overt male
sexual behavior in rats. The male rat sexual behavior paradigm
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FIGURE 5 | Sexual behavior of male rats from normal ejaculating rats treated with 0, 0.25, 1, or 4 mg/kg S15535. The number and latency of ejaculations per 30 min
(A,D), number and latency of Mounts (B,E), number and latency of Intromissions (C,F), post-ejaculatory interval (G), and Intromission Ratio (H) of the first Ejaculation
Series are provided. Detailed statistical analyses are displayed in Supplementary Table 3. +Significant difference between SERT+/+ and SERT−/− groups.
used in the present studies has been developed over the last
decades (Pattij et al., 2005; Chan et al., 2008; Olivier et al., 2011),
specifically to test the effects of psychoactive drugs, including
antidepressants (Waldinger and Olivier, 2005; Chan et al., 2010;
Heijkoop et al., 2018). The paradigm is able to distinguish acute
effects of drugs like the pro-sexual effects of 5-HT1A receptor
agonists (Pattij et al., 2005), but also the chronic inhibitory effects
of SSRI antidepressants (Chan et al., 2010, 2011; Bijlsma et al.,
2014). Pro-sexual effects of drugs in male rat sexual behavior are
reflected in the speed of onset of sexual activity toward a newly
introduced female in behavioral estrus; reflected in a shorter
interval to reach ejaculation (Andersson and Larsson, 1994),
including reduced number of mounts and intromissions to reach
ejaculation and enhanced number of ejaculations over a certain
test period (in our case 30 min). Reduction of sexual behavior,
e.g., by chronic antidepressants (Chan et al., 2010; Bijlsma et al.,
2014) has reversed effects. This chronic SSRI (antidepressant)-
induced profile of reduced male sexual behavior is comparable to
the sexual behavior of SERT−/− rats and supports the hypothesis
that male SERT−/− rats are modeling the sexual effects of chronic
SSRI administration (Chan et al., 2011; Olivier et al., 2011).
Several studies on SERT-genotypes in sexual behavior have been
performed in at least three different labs (Utrecht, Groningen,
Netherlands) and Hefei (China: Geng et al., 2019). In all three
independent studies male SERT−/− rats display a significantly
lower level of sexual behavior than SERT+/+ rats (Olivier et al.,
2011; Geng et al., 2019; Olivier and Olivier, 2019). It can be
suggested that full absence of the SERT reduces the level of each
individual rat’s sexual behavior. It can be speculated that the
resulting sexual phenotype of a SERT−/− rat may be derived from
a certain basic sexual behavior that in some way is permanently
inhibited when the SERT is absent from conception on. This
can also be illustrated by the comparable ejaculation curves
(# ejaculations after training) for both genotypes of which the
SERT−/− rats are shifted to the left compared to the SERT+/+
rats (Olivier and Olivier, 2019). The typical distribution patterns
of the # of ejaculations (or the 1st ejaculation latency times)
in a large cohort of SERT-genotypes (Olivier and Olivier, 2019)
supplies us with the possibility to behaviorally match animals
with a certain genotype, e.g., only high versus low sexually
performing animals, as we did previously in the study of tramadol
effects on male sexual behavior (Esquivel-Franco et al., 2018).
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FIGURE 6 | Sexual behavior of male rats from slow ejaculating treated with 0, 0.25, 1, or 4 mg/kg S15535. The number and latency of ejaculations per 30 min (A,D),
number and latency of Mounts (B,E), number and latency of Intromissions (C,F) and Intromission Ratio (G) of the first Ejaculation Series are given. Detailed statistical
analyses are shown in Supplementary Table 4. a: significant difference (p < 0.05) compared to saline group, c: significant difference (p < 0.05) compared to
1/mg/kg group. +Significant difference between SERT+/+ and SERT−/− (p < 0.05).
In the present experiments we intentionally created (Exp. 2) two
groups of SERT+/+ and SER−/− rats with low (not statistically
different) levels of sexual behavior in order to circumvent possible
interference of high versus low rates of behavior.
Two biased 5-HT1A receptor agonists, the preferential
5-HT1A auto-receptor agonist F13714 (Assié et al., 2006;
TABLE 4 | Overview of ejaculatory responses to 5-HT1A receptor agonists in
SERT+/+ and SERT−/−-/ rats.







SERT+/+ rats ↑ ↑ at lower dose No effect No effect
SERT−/− rats ↑ ↑ at higher dose No effect No effect
↑: increased ejaculation frequency.
Becker et al., 2016) and the preferential 5-HT1A heteroreceptor
agonist F15599 (Newman-Tancredi et al., 2009; Becker et al.,
2016) were tested in SERT+/+ and SERT−/− rats. Both
compounds induced pro-sexual activity in SERT+/+ and
SERT−/− rats (for overview see Table 4). F13714 is considerably
more potent than F15599 in eliciting the pro-sexual effects,
but the similarity of the response of both compounds on male
sexual behavior suggests that both compounds share comparable
mechanisms of action in evoking sexual behavior. This may
point to an autoreceptor-mediated effect. Unfortunately, full
dose-response curves of this pro-sexual effect were not available
for both compounds making definite conclusions impossible. In
F13714-treated SERT−/− rats the dose-response curve of pro-
sexual activity was shifted to the right compared to SERT+/+
rats, but this was not the case in F15599 treated rats where
the sexual inhibiting doses were comparable in both genotypes.
5-HT1A receptor stimulation by “non-selective” (with regard
to pre- and post-synaptic receptors) 5-HT1A receptor agonists
like 8-OH-DPAT, flesinoxan, buspirone, ipsapirone, and others
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(Olivier et al., 1999) have pro-sexual effects in wildtype rats
(Snoeren et al., 2014 for review), but no studies were performed
before where the specific contributions of 5-HT1A auto-
receptors or 5-HT1A heteroreceptors (or both) are investigated.
S15535, an auto-receptor selective 5-HT1A receptor agonist and
heteroreceptor-selective 5-HT1A receptor antagonist, did not
have any effects on male sexual behavior of SERT+/+ and
SERT−/− rats, neither in normal ejaculating (on average 1–
2 ejaculations/30 min; group 1) nor in slow ejaculating (0–1
ejaculations/30 min; group 2) rats. We conclude that S15535
behaves as a “silent” 5-HT1A receptor ligand in male rat
sexual behavior.
The prototypal 5-HT1A receptor agonist (±) or (+)-8-OH-
DPAT, a non-selective auto-receptor and heteroreceptor agonist
(Larsson et al., 1990), has strong and dose-dependent pro-sexual
effects (Mos et al., 1991; Chan et al., 2011; Snoeren et al.,
2014). This pro-sexual effect can be fully antagonized by the
5-HT1A receptor antagonist WAY100,635, a behaviorally silent
compound (de Jong and Neumann, 2015). In male SERT−/− rats
(Chan et al., 2011) 8-OH-DPAT had pro-sexual effects, although
(like the biased agonist F13714 in the present study) the dose-
response curve was shifted to the right compared to SERT+/+
rats. The lack of any behavioral effect of S15535 in either
SERT+/+ or SERT−/− rats is rather puzzling. Apparently, 5-
HT1A receptor antagonistic activity on 5-HT1A heteroreceptors
in SERT−/− rats did not cause inhibition of male sexual behavior
like WAY100,635 treatment (Chan et al., 2011). The stimulating
effect of F13714 and F15599 in male sexual behavior in both
SERT+/+ and SERT−/− rats is also quite puzzling, because it
makes explanations in term of pre- or post-synaptic 5-HT1A
receptor mechanisms involved, troublesome. However, it remains
possible that the preferential post-synaptic 5-HT1A receptor
agonist F15599, at higher doses (like in this experiment) also
displays some presynaptic autoreceptor agonistic activity. In that
case F15599 does not appear the specific tool to selectively
activate post-synaptic 5-HT1A heteroreceptors.
How do the sexual data obtained with these three serotonergic
ligands compare to their effects in other behavioral systems?
The research group of De Boer (de Boer and Newman-Tancredi,
2016) has tested these (and other) ligands extensively in male rat
models of offensive aggression in Wildtype Groningen (WTG)
rats. In male rat offensive aggression (de Boer et al., 1999, 2000)
8-OH-DPAT potently and dose-dependently reduced offensive
aggression but also induces strong sedative-like behaviors.
Because 5-HT1A receptor agonists induce a so-called serotonin-
5-HT1A syndrome, characterized by Lower Lip Retraction (LLR),
Forepaw Treading (FPT), and Flat Body Posture (FBP), it is
not completely clear whether this sedative-like activity is similar
to these serotonergic behaviors. These anti-aggressive and other
effects of 8-OH-DPAT can be fully antagonized by WAY100,635
(de Boer et al., 1999, 2000), a silent antagonist in offensive
aggression. F13714, F15599, and S15535 all reduce offensive
aggression (de Boer and Newman-Tancredi, 2016). Both F13714
and F15599 induce a serotonergic-5-HT1A syndrome in rats
(Newman-Tancredi et al., 2009; Assié et al., 2010; Jastrzȩbska-
Wiȩsek et al., 2018). S15535 does not induce the serotonergic-
5-HT1A syndrome at all (de Boer and Newman-Tancredi, 2016;
Jastrzȩbska-Wiȩsek et al., 2018) and also has no sedative-
like activity in offensive aggression (de Boer et al., 2000).
WAY100,635 antagonized the anti-aggressive action of S15535,
F15599, and F13714 (de Boer and Newman-Tancredi, 2016).
If the mechanisms of action of the three 5-HT1A ligands
as extensively investigated by various research groups are true,
mechanistic interpretations of the behavioral effects found in
male sexual behavior are rather difficult to make. Serotonergic 5-
HT1A auto-receptors in the raphe nuclei are generally considered
as, upon activation, leading to inhibition of cell firing and
consequently a decrease of serotonin release. Subsequently,
all post-synaptic 5-HT (hetero) receptors (including 5-HT1A
heteroreceptors) receive diminished or no stimulation by
serotonin and depending on the coupling of the post-synaptic
receptor to different transduction mechanisms the neuron
involved will be activated or inhibited. Serotonin is also known
to crosstalk with non-serotonergic systems which may exert
effects on (sexual) behavior as well (e.g., Blier, 2001). In
case of a non-selective 5-HT1A receptor agonist like 8-OH-
DPAT, next to its inhibiting action on the serotonergic neuron,
direct 5-HT1A heteroreceptor stimulation still occurs leading
to post-synaptically mediated effects, like the serotonergic-5-
HT1A behavioral syndrome (Berendsen et al., 1990; Jastrzȩbska-
Wiȩsek et al., 2018). In the case of F13714, a relatively selective
(compared to heteroreceptor) 5-HT1A auto-receptor agonist
(Assié et al., 2006) potently facilitated sexual activity in male
SERT+/+ rats suggesting that pro-sexual activity is related to
activation of 5-HT1A auto-receptors. The relatively selective 5-
HT1A heteroreceptor agonist F15599 also facilitated male sexual
activity in SERT+/+ rats. The difference in potency (factor
256 difference) to obtain the pro-sexual activity (at the lowest
effective dose) can possibly be explained by the difference of
the in vitro and in vivo affinity and efficacy of both compounds
on 5-HT1A receptors (Assié et al., 2010; Newman-Tancredi,
2011; Jastrzȩbska-Wiȩsek et al., 2018). This might be taken as
suggestive that both compounds exert pro-sexual activity via
activation of 5-HT1A auto-receptors. Strangely enough, both
compounds also activate the serotonergic-5-HT1A syndrome
(Newman-Tancredi, 2011; Becker et al., 2016). The 5-HT1A auto-
receptor agonist S15535 does not induce pro-sexual behavior,
neither in normal nor in sexually slow ejaculating rats. Whether
blocking of post-synaptic 5-HT1A heteroreceptors antagonizes
the expected pro-sexual effect of the auto-receptor stimulation
is rather difficult to envisage. This would assume a rather
high level of basal activity of 5-HT1A heteroreceptors involved
in sexual behavior. Interestingly, Pattij et al. (2005) showed
that slow, normal and rapid ejaculating rats showed increased
ejaculations after treatment with 8-OH-DPAT; however, when
rats were re-tested 1 week after this 5-HT1A receptor agonist
administration all phenotypes returned to ejaculatory behavior
levels found before the 8-OH-DPAT treatments. In the present
study we found that during the weeks where treatment
with S155355 were administered, the saline groups (and thus
baseline levels) showed significant higher ejaculation frequencies
compared to the ejaculation frequencies during the training
weeks. This might suggest that pro-sexual effects due to
5-HT1A receptor agonist can be long-lasting, most likely
Frontiers in Behavioral Neuroscience | www.frontiersin.org 12 March 2020 | Volume 14 | Article 40
fnbeh-14-00040 March 28, 2020 Time: 18:58 # 13
Esquivel-Franco et al. 5-HT1A Receptors in Sexual Behavior
due to alterations in the 5-HT1A receptors. Further research is
warranted to investigate how long this effect would persist and
whether it is, 1 week after all treatments with 5-HT1A receptor
agonists, and without saline treatment, still present.
SERT−/− rats, a model of permanently changed serotonergic
activity in the brain (Homberg et al., 2007) and associated
with an altered sexual phenotype (Chan et al., 2011) may be
helpful in explaining the behavioral effects found for the three
compounds. Chan et al. (2011) have found that 8-OH-DPAT
has pro-sexual effects in male SERT−/− rats, although the
dose-response curve has been shifted to the right compared
to SERT+/+ rats. Remarkably, WAY100,635, a non-selective
5-HT1A receptor antagonist and without any behavioral effects in
SERT+/+ males, was (dose-dependently) inhibitory in SERT−/−
rats. WAY100,635 was able to completely antagonize the pro-
sexual effects of 8-OHDPAT in SERT+/+ rats but only partially in
SERT−/− rats (Chan et al., 2011). We concluded from these data
that complete absence of SERT molecules had led to alterations
in 5-HT1A receptor functioning, hypothesizing that one pool of
5-HT1A receptors mediates pro-sexual effects of 5-HT1A receptor
stimulation and is not (de)sensitized, whereas another pool of
5-HT1A receptors, mediating the inhibitory effects of antagonized
5-HT1A receptors seems sensitized in the SERT−/− rats. The
hypothesis of two differentially regulated 5-HT1A receptor pools
in SERT−/− rats has also been found in autonomic regulation
of body temperature and stress (Olivier et al., 2008). The
findings with F15599 and F13714 in the SERT−/− rats cannot be
explained in terms of action on different 5-HT1A receptor pools.
If any, both compounds seem to activate the pool mediating
the pro-sexual effects. The 5-HT1A heteroreceptor antagonistic
effects of S15535 do not lead to inhibition of male sexual behavior
in the better performing (normal ejaculating) SERT−/− rats, as
was the case for WAY100,635 in the Chan et al. (2011) study.
Our expectation that biased 5-HT1A receptor agonists and a
mixed 5-HT1A presynaptic receptor agonist and post-synaptic
antagonist might help to reveal the potential contribution of these
different 5-HT1A receptors was too optimistic. The mechanisms
of action of the respective molecules are probably to complex,
especially in vivo in complicated networks, where 5-HT1A
receptors interact with various other neurotransmitter systems in
the modulation of male sexual behavior.
CONCLUSION
The data collected with the pharmacological experiments show
that selective (preferential) pre- and postsynaptic 5-HT1A
receptor agonists possess pro-sexual effects in SERT+/+ and
SERT−/−, although the response is diminished in SERT−/−
animals, most likely due to desensitization of 5-HT1A receptors.
The pharmacological experiment with S15535 compared with
previous experiments performed in aggression lacked any sexual
behavioral effect. Further experiments are needed to explore
whether separate neurobiological substrates at the 5-HT1A
receptors level exist.
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